The Board of Directors of the Company in its Meeting held today i.e. Friday, May 30, 2025 has considered and approved the Audited Financial Results / Statements of the Company for the Quarter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 4.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved audited standalone financial results for Q4 and FY25, audited by M/s SPARK & Associates with an unmodified (clean) opinion. Revenue from operations rose marginally to Rs. 1,137.96 lakhs in Q4 (vs Rs. 1,124.72 lakhs YoY) and to Rs. 4,128.77 lakhs for the full year (vs Rs. 4,089.47 lakhs), barely 1% growth. FY25 net profit stood at Rs. 7.99 lakhs, swinging from a loss of Rs. 194.71 lakhs last year — the improvement is largely because there were no exceptional items this year, compared with Rs. 279.29 lakhs of retirement-related exceptional charges in FY24. The company operates in a single segment (gelatine and by-products).
The headline return to profit looks positive but is shallow and driven by the absence of one-time charges rather than strong operating performance — revenue growth is negligible. Shareholders should note the balance sheet remains weak: other equity is still negative at Rs. -62.56 lakhs and total borrowings of about Rs. 2,096 lakhs against equity of Rs. 418.77 lakhs imply a debt-to-equity ratio near 5x, which is a key concern for the stock.